Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Robenacoxib is a non-steroidal anti-inflammatory drug (NSAID) and COX-2 inhibitor (Ki = 30 nM for the human enzyme).1 It is selective for COX-2 over COX-1 (Ki = 800 nM for the ovine enzyme). Robenacoxib inhibits IL-1β-induced prostaglandin E2 (PGE2; Item No. 14010) production in human dermal fibroblasts (IC50 = 31 nM). It reduces carrageenan-induced paw edema (ID50 = 0.4 mg/kg), has antinociceptive activity in the Randall-Selitto test, and inhibits LPS-induced fever in rats. Formulations containing robenacoxib have been used in the treatment of post-operative pain and inflammation in cats.
WARNING This product is not for human or veterinary use.
1. Preclinical pharmacology of robenacoxib: A novel selective inhibitor of cyclooxygenase-